Every week new GLP-1 telehealth brands launch, and from the landing page a legitimate medical practice and a gray-market storefront look identical — same stock photos, same before/afters, same "board-certified providers" copy. The differences live one layer down, and checking them takes ten minutes. Here is the exact routine.
Key Takeaways
- Five checks: business identity, prescriber licensing model, pharmacy identification, certification status, and terms/pricing sanity.
- The single fastest tell: whether a prescription from a state-licensed clinician is actually required. 'No prescription needed' ends the evaluation.
- LegitScript certification is a meaningful positive signal for telehealth pharmacies and platforms; its absence is a question, not a verdict.
- If the price is dramatically below the legitimate market, the savings are coming out of sourcing, testing, or medicine itself.
Minute 1–2: Who Are They, Legally?
Scroll to the footer. You're looking for a real legal entity name, a physical address, and terms of service that name the medical group actually providing care (telehealth brands typically operate alongside an affiliated professional entity — its presence in the fine print is a good sign, not a shell game). No entity, no address, no terms: stop here.
Minute 3–4: The Prescription Test
Confirm the flow requires a medical intake reviewed by a clinician licensed in your state, with identity verification. Any site offering to ship semaglutide or tirzepatide without a prescription — or selling it as "research chemicals" with a wink — is not a shortcut past telehealth; it's an unregulated substance of unknown identity and dose. This single test filters out the worst actors instantly.
Minute 5–6: Find the Pharmacy
Ask (or search their FAQ): which pharmacy fills the prescriptions? Legitimate platforms name their compounding pharmacy partners or disclose them on the vial label at minimum. Take the pharmacy name to its home state's Board of Pharmacy license lookup — active license, and note anything on the disciplinary record. Two minutes, and you've verified the party actually making your medication.
Minute 7–8: Certification Signals
Search the LegitScript database for the platform and/or pharmacy. LegitScript certification — the standard used by major ad networks to allow healthcare advertising — indicates the operation passed real vetting of its licensing and practices. Certified is a solid green flag. Uncertified is a question mark to weigh with everything else, since some legitimate operations simply haven't gone through the process.
Minute 9–10: Terms and Price Sanity
In the terms, find: cancellation notice window, refund policy, and auto-ship mechanics — you want to know the exit before the entrance. Then the price check: compare against the going legitimate compounded market (roughly $49–$250/month across commitment structures in mid-2026). Wildly below that band isn't a deal; it's a disclosure.
Providers That Pass This Screen
Programs we currently track that clear the routine above:
Embody
Injectable semaglutide — $149 first month
Physician-supervised injectable semaglutide with fast async intake and flat pricing after month one.
Compounded medications are not FDA-approved.
Visit Embody Paid linkEnhance MD
Injectable GLP-1 program
Established telehealth clinic with injectable GLP-1 protocols and live provider access.
Compounded medications are not FDA-approved.
Visit Enhance MD Paid linkSesame Care
Brand-name only — Rybelsus and oral Wegovy from $149–$299/mo
Brand-name FDA-approved medications only through a transparent marketplace — no compounded products.
Visit Sesame Care Paid linkTen minutes, five checks, once per provider. It's the best-paying diligence in consumer health.
Affiliate disclosure: Links marked "Paid link" are affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. This supports our independent research.
Compounded medication notice: Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Brand-name alternatives (Wegovy, Ozempic, Zepbound, Rybelsus) are FDA-approved.
Medical disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications are prescription drugs. Always consult a licensed healthcare provider about diagnosis, treatment, dosing, and whether these medications are appropriate for you.